6-29942488-G-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The ENST00000706894.1(HLA-A):c.-66G>T variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.065 ( 848 hom., cov: 18)
Exomes 𝑓: 0.092 ( 10429 hom. )
Failed GnomAD Quality Control
Consequence
HLA-A
ENST00000706894.1 5_prime_UTR
ENST00000706894.1 5_prime_UTR
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -4.96
Publications
6 publications found
Genes affected
HLA-A (HGNC:4931): (major histocompatibility complex, class I, A) HLA-A belongs to the HLA class I heavy chain paralogues. This class I molecule is a heterodimer consisting of a heavy chain and a light chain (beta-2 microglobulin). The heavy chain is anchored in the membrane. Class I molecules play a central role in the immune system by presenting peptides derived from the endoplasmic reticulum lumen so that they can be recognized by cytotoxic T cells. They are expressed in nearly all cells. The heavy chain is approximately 45 kDa and its gene contains 8 exons. Exon 1 encodes the leader peptide, exons 2 and 3 encode the alpha1 and alpha2 domains, which both bind the peptide, exon 4 encodes the alpha3 domain, exon 5 encodes the transmembrane region, and exons 6 and 7 encode the cytoplasmic tail. Polymorphisms within exon 2 and exon 3 are responsible for the peptide binding specificity of each class one molecule. Typing for these polymorphisms is routinely done for bone marrow and kidney transplantation. More than 6000 HLA-A alleles have been described. The HLA system plays an important role in the occurrence and outcome of infectious diseases, including those caused by the malaria parasite, the human immunodeficiency virus (HIV), and the severe acute respiratory syndrome coronavirus (SARS-CoV). The structural spike and the nucleocapsid proteins of the novel coronavirus SARS-CoV-2, which causes coronavirus disease 2019 (COVID-19), are reported to contain multiple Class I epitopes with predicted HLA restrictions. Individual HLA genetic variation may help explain different immune responses to a virus across a population.[provided by RefSeq, Aug 2020]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.94).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.315 is higher than 0.05.
Variant Effect in Transcripts
ACMG analysis was done for transcript: ENST00000706894.1. You can select a different transcript below to see updated ACMG assignments.
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| HLA-A | c.-66G>T | 5_prime_UTR | Exon 2 of 8 | ENSP00000516610.1 | A0A9L9PYF9 | ||||
| HLA-A | TSL:6 | c.-66G>T | 5_prime_UTR | Exon 1 of 8 | ENSP00000366002.5 | Q5SRN5 | |||
| HLA-A | c.-66G>T | 5_prime_UTR | Exon 2 of 9 | ENSP00000516611.1 | Q5SRN5 |
Frequencies
GnomAD3 genomes AF: 0.0647 AC: 7782AN: 120270Hom.: 848 Cov.: 18 show subpopulations
GnomAD3 genomes
AF:
AC:
7782
AN:
120270
Hom.:
Cov.:
18
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.0918 AC: 67988AN: 740662Hom.: 10429 Cov.: 10 AF XY: 0.0965 AC XY: 36537AN XY: 378478 show subpopulations
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
67988
AN:
740662
Hom.:
Cov.:
10
AF XY:
AC XY:
36537
AN XY:
378478
show subpopulations
African (AFR)
AF:
AC:
238
AN:
17574
American (AMR)
AF:
AC:
1177
AN:
19054
Ashkenazi Jewish (ASJ)
AF:
AC:
1077
AN:
13202
East Asian (EAS)
AF:
AC:
6087
AN:
23750
South Asian (SAS)
AF:
AC:
10266
AN:
53458
European-Finnish (FIN)
AF:
AC:
1866
AN:
32992
Middle Eastern (MID)
AF:
AC:
293
AN:
3212
European-Non Finnish (NFE)
AF:
AC:
43848
AN:
544178
Other (OTH)
AF:
AC:
3136
AN:
33242
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.562
Heterozygous variant carriers
0
1224
2448
3673
4897
6121
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
1318
2636
3954
5272
6590
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0646 AC: 7778AN: 120354Hom.: 848 Cov.: 18 AF XY: 0.0682 AC XY: 3945AN XY: 57838 show subpopulations
GnomAD4 genome
AF:
AC:
7778
AN:
120354
Hom.:
Cov.:
18
AF XY:
AC XY:
3945
AN XY:
57838
show subpopulations
African (AFR)
AF:
AC:
497
AN:
33160
American (AMR)
AF:
AC:
603
AN:
10834
Ashkenazi Jewish (ASJ)
AF:
AC:
192
AN:
2882
East Asian (EAS)
AF:
AC:
1290
AN:
3906
South Asian (SAS)
AF:
AC:
750
AN:
3812
European-Finnish (FIN)
AF:
AC:
347
AN:
7680
Middle Eastern (MID)
AF:
AC:
16
AN:
248
European-Non Finnish (NFE)
AF:
AC:
3893
AN:
55486
Other (OTH)
AF:
AC:
100
AN:
1592
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.605
Heterozygous variant carriers
0
143
286
430
573
716
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
98
196
294
392
490
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.